Free Shipping in the U.S. for orders over $1000.  Shop Now>>

NeoBiotechnologies Receives 2023 Best of Union City Award

Press Release

FOR IMMEDIATE RELEASE

NeoBiotechnologies Receives 2023 Best of Union City Award

Union City Award Program Honors the Achievement

UNION CITY September 5, 2023 — NeoBiotechnologies has been selected for the 2023 Best of Union City Award in the Biotechnology Company category by the Union City Award Program.

Each year, the Union City Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small business through service to their customers and our community. These exceptional companies help make the Union City area a great place to live, work and play.

Various sources of information were gathered and analyzed to choose the winners in each category. The 2023 Union City Award Program focuses on quality, not quantity. Winners are determined based on the information gathered both internally by the Union City Award Program and data provided by third parties.

About Union City Award Program

The Union City Award Program is an annual awards program honoring the achievements and accomplishments of local businesses throughout the Union City area. Recognition is given to those companies that have shown the ability to use their best practices and implemented programs to generate competitive advantages and long-term value.

The Union City Award Program was established to recognize the best of local businesses in our community. Our organization works exclusively with local business owners, trade groups, professional associations and other business advertising and marketing groups. Our mission is to recognize the small business community’s contributions to the U.S. economy.

SOURCE: Union City Award Program

Media Contact:
Union City Award Program
Email: PublicRelations@citiesawardcompany.com
URL: https://www.citiesawardcompany.com

PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK